ScholarIQanswers from OpenAlex

Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin.

PaperCitations, authors & open-access status

Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin. is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin. have?

ScholarIQcitation count

Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin. has 9 citations in the OpenAlex counts ScholarIQ stores.

When was Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin. published?

ScholarIQyear

Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin. has 2011 year in the ScholarIQ index.

What is the open-access status of Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin.?

ScholarIQoa status

Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin. has closed oa status in the ScholarIQ index.

What is the PMID of Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin.?

ScholarIQpmid

The PMID for Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin. is on the source record.

What is the OpenAlex record for Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin.?

ScholarIQopenalex

The OpenAlex for Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin. is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial